37th EDRN Steering Committee Meeting/EDRN Lung & Upper Aerodigestive Cancers Collaborative Group Meeting Draft Agenda

 Tuesday, October 19, 2021

10:00 a.m. to 5:00 p.m. Eastern Daylight Time

Chair: James Herman, MD, University of Pittsburgh Cancer Institute

Co-chair:  Steven Dubinett, MD, University of California, Los Angeles

NCI Program Directors: Lynn Sorbara, PhD, and Karl Krueger, PhD, National Cancer Institute

 

Agenda

 

10:00 a.m. – 5:00 p.m.

Collaborative Group Meetings

 

Moderators: Lynn Sorbara, PhD, Karl Krueger, PhD, National Cancer Institute

 

10:00 a.m. – 3:00 p.m.

Team Projects and Projects Supported with CORE Funds

o    What was accomplished and what remains to be done

o    Feasibility of completion

o    Lessons learned

o    Recommendations for improvements

10:00 a.m. – 10:30 a.m.

01: Lung Cancer Screening in a High-Rick Underrepresented Cohort of Low-Income and African Americans

Eric Grogan, MD - Vanderbilt University

Validating an Integrated Biomarker and Imaging Approach in the Evaluation of Indeterminate Pulmonary Nodules (IPNs)

Stephen Deppen, PhD- Vanderbilt University

 

10:30 a.m. – 10:40 a.m.

Q/A

 

10:40 a.m. – 11:10 a.m.

02: Collaborative Studies of Lung Cancer Associated Airway Gene Expression and Plasma markers

Marc Lenburg, PhD - Boston University

Steven Dubinett, MD, UCLA

 

11:10 a.m.  – 11:20 a.m.

Q/A

 

 

11:20 a.m. – 12:00 p.m.

03: International Collaborations: Failure and Success

Harvey Pass, MD – New York University

 

 

12:00 p.m. – 12:10 p.m.

Q/A

 

 

12:10 p.m. – 12:30 p.m.

Break

 

 

12:30 p.m. – 12:50 p.m.

04: Longitudinal Study with Samples from Israel

Louise Showe, PhD – Wistar Institute

 

 

12:50 p.m. – 1:00 p.m.

Q/A

 

 

1:00 p.m. – 1:20 p.m.

05: Phase 2 validation of Airway Epithelial Cell TP53 Mutation Biomarker for Lung Cancer Risk

James Willey, MD – University of Toledo

 

 

1:20 p.m. – 1:30 p.m.

Q/A

 

 

1:30 p.m. – 1:50 p.m.

06: Radiomic Classifiers for Incidental Pulmonary Nodules

Matthew Schabath, PhD – Moffitt Cancer Center

 

 

1:50 p.m. – 2:00 p.m.

Q/A

 

 

2:00 p.m. – 2:20 p.m.

07: Non-coding RNAs (ncRNAs) as Biomarkers for Early Detection of Non-Small Cell Lung Cancer

Feng Jiang, PhD/Sanford Stass, MD, University of Maryland School of Medicine

 

 

2:20 p.m. – 2:30 p.m.

Q/A

 

 

2:30 p.m.  – 3:00 p.m.

08: Plasma and Urine Detection of DNA Methylation in Diverse Populations Methylation Marker Detection of Multiple Cancers in ctDNA

Jim Herman, MD – University of Pittsburgh

 

 

3:00 p.m. – 3:10 p.m.

Q/A

 

 

3:10 p.m. – 3:30 p.m.

Session Wrap Up

 

 

3:30 p.m. – 3:50 p.m.

Break

 

 

3:50 p.m. – 5:00 p.m.

Discussion of Potential Clinical Utility Trials

Moderators: 

o   James Herman, MD, University of Pittsburgh Cancer institute

o   Steven Dubinett, MD, University of California, Los Angeles

 

 

3:50 p.m. – 4:50 p.m.

Discussion focus: Clinical applications and Trial Design

 

 

4:50 p.m. – 5:00 p.m.

Wrap-up of this session

 

 

5:00 p.m.

Adjourn

 

 

Version 5.1.1